Abstract
Aim
To document the long-term outcomes of pneumococcal meningitis in children presenting to a Dublin paediatric hospital in the pre-pneumococcal conjugate vaccine (PCV7) era (1998–2007).
Methods
Subjects with pneumococcal meningitis were identified at The Children’s University Hospital, Dublin through the hospital surveillance system and laboratory archives.
Results
44 children were identified with S. pneumoniae meningitis. Mean age of presentation was 23.45 months (2 days to 13 years) and 28 (65%) cases were less than 12 months old. Eight (18.6%) children died. 55% of cases were left with significant deficits. Of the survivors, 7 (20%) had moderate to severe neurological sequelae.
Conclusion
Pneumococcal meningitis is a devastating childhood disease with significant mortality and morbidity, especially in those less than 2 years of age. These data provide a baseline against which the impact of PCV7 on pneumococcal meningitis can be measured.
Similar content being viewed by others
References
Jefferson T, Ferroni E, Curtale F et al (2006) Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 6:405–410
Swartz MN (2004) Bacterial meningitis—a view of the past 90 years. N Engl J Med 351:1826–1828
Arditi M, Mason EO, Bradley JS et al (1998) Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102:1087–1097
Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002; 35: 547–55
Hausdorff WP, Bryant J, Paradiso PR et al (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part 1. Clin Infect Dis 30:100–121
Hausdorff WP, Bryant J, Kloek C et al (2000) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part 2. Clin Infect Dis 30:122–140
Fitzsimons JJ, Chong AL, Cafferkey MT, Butler KM (2008) Invasive pneumococcal disease in children in Ireland—the anticipated benefit of conjugate pneumococcal vaccination. IrJ Med Sci. 177(3):225–231 Epub 2008 Jun 27
McIntyre PB, Macintyre CR, Gilmour R, Wang H (2005) A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child 90(4):391–396
van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004405
Centers for Disease Control and Prevention (CDC) (2008) Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction–eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 57(6):144–148
Perrocheau A, De Benoist AC, Six C et al (2002) Epidemiology of bacterial meningitis in France in 1999. Ann Med Interne 153:311–317
Ada G (2001) Vaccines and vaccination. N Engl J Med 345(14):1042–1053
Musher DM (2006) Pneumococcal vaccine—direct and indirect (“herd”) effects. N Engl J Med 354(14):1522–1524
Hicks LA, Harrison LH, Flannery B et al (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196(9):1346–1354 Epub 2007 Oct 4
Scott DA, Komjathy SF, Hu BT, Baker S, Supan LA, Monahan CA, Gruber W, Siber GR, Lockhart SP (2007) Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 25(33):6164–6166 Epub 2007 Jun 26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lucey, J.M., Gavin, P., Cafferkey, M. et al. Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999–2007. Ir J Med Sci 180, 47–50 (2011). https://doi.org/10.1007/s11845-010-0620-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-010-0620-1